Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Biocon Academy - Biocon
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon - Crunchbase Company Profile & Funding
Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Biocon Q4 results show Consolidated revenue up by 21% - The Statesman
Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion | The Financial Express
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Fortune India: Business News, Strategy, Finance and Corporate Insight
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
Biocon logo in transparent PNG format
Syngene International: Biocon sells 5.4% stake in arm Syngene International - The Economic Times
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
Manufacturing Locations - Biocon
Biocon Campus - Biocon
Biocon announces merger of its arm with Serum Institute subsidiary - BusinessToday
Biocon engages law firm for governance review after CBI arrests
Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets | Deccan Herald
Biocon Biologics Limited | ISPE | International Society for Pharmaceutical Engineering
Biocon - Wikipedia
